Abdullah Saud Alshetaili

Pharmacology, Toxicology and Pharmaceutical Science

1. Nanoparticle 100%
2. Tablet 87%
3. Bioavailability 83%
4. Drug Delivery System 56%
5. Drug Release 55%
6. Pharmacokinetic 47%
7. Nanogel 43%
8. Rat 42%
9. Mefenamic Acid 41%
10. Breast Cancer 41%
11. Zeta Potential 37%
12. Povidone 33%
13. Differential Scanning Calorimetry 32%
14. Chitosan 32%
15. Drug Solubility 30%
16. Poloxamer 28%
17. Carbon Dioxide 28%
18. Polyglactin 26%
19. Solid Lipid Nanoparticle 24%
20. Eudragit 24%
21. Amorphous Solid Dispersion 22%
22. Lipid 22%
23. Cytotoxicity 22%
24. Sustained Release 22%
25. Lung Cancer 21%
26. Malignant Neoplasm 21%
27. Simvastatin 20%
28. Fenofibrate 20%
29. Sunitinib 20%
30. Luteolin 20%
31. Scanning Electron Microscopy 20%
32. Anticarcinogen 19%
33. Nanocarrier 18%
34. Anti-Inflammatory Drug 18%
35. Inflammation 17%
36. Atopic Dermatitis 17%
37. Cytokine 16%
38. Polyethylene Glycol 15%
39. Non Small Cell Lung Cancer 15%
40. Pharmacodynamics 15%
41. Ibrutinib 15%
42. Intravaginal Administration 15%
43. Carbamazepine 15%
44. Excipient 14%
45. Dosage Form 14%
46. Pharmaceutics 13%
47. Macrogol 13%
48. Antioxidant 13%
49. Antihypertensive Agent 13%
50. Chemokine 13%